Page last updated: 2024-10-30

mesalamine and Methemoglobinemia

mesalamine has been researched along with Methemoglobinemia in 2 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Methemoglobinemia: The presence of methemoglobin in the blood, resulting in cyanosis. A small amount of methemoglobin is present in the blood normally, but injury or toxic agents convert a larger proportion of hemoglobin into methemoglobin, which does not function reversibly as an oxygen carrier. Methemoglobinemia may be due to a defect in the enzyme NADH methemoglobin reductase (an autosomal recessive trait) or to an abnormality in hemoglobin M (an autosomal dominant trait). (Dorland, 27th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Druez, A1
Rahier, JF1
Hébuterne, X1
Azad Khan, AK1
Nurazzaman, M1
Truelove, SC1

Trials

1 trial available for mesalamine and Methemoglobinemia

ArticleYear
The effect of the acetylator phenotype on the metabolism of sulphasalazine in man.
    Journal of medical genetics, 1983, Volume: 20, Issue:1

    Topics: Acetylation; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Humans; Mesalamine

1983

Other Studies

1 other study available for mesalamine and Methemoglobinemia

ArticleYear
Methaemoglobinaemia and renal failure following mesalazine for treatment of inflammatory bowel disease.
    Journal of Crohn's & colitis, 2014, Volume: 8, Issue:8

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Inflammatory Bowel Diseases; Mesalamine; Me

2014